RQ Biotechnology Limited
PrivateLast Round
Series A
Jun 24, 2026
Total Funding Raised
$230M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
RQ Biotechnology Limited is a biotechnology company that develops potent, broad-spectrum monoclonal antibodies to provide passive immunization against viral infections for vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RQ Biotechnology Limited Comparables
Compare RQ Biotechnology Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthLinks Bio | 74% | |
| AstraZeneca | 71% | |
| Merck & Co., Inc. | 68% | |
RQ Biotechnology Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 24, 2026 | ||||
| Series A | Jun 24, 2024 |
Key People
Founding team and executive leadership
RQ Biotechnology Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A |
| Oxford Science Enterprises | Series A |
| Monograph Capital | Series A |
| University of Oxford | Series A |
| Frazier Life Sciences | Series A |
| LifeArc Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 4, representing 25% of headcount.
- Aug 1, 2026
Grew 19% QoQ from 16 to 19 employees.
RQ Biotechnology Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RQ Biotechnology Limited's valuation, stock price, and market status.